K073390

Substantially Equivalent

DIASORIN LIASON RUBELLA IGG ASSAY; DIASORIN LIAISON RUBELLA IGG TRI-CONTROLS

Applicant: DiaSorin, Inc.
Product code: LFX
Advisory panel: Microbiology
Date received: 2007-12-03
Decision date: 2008-11-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Stillwater, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.